CLINICAL_TRIALS
trial_result
· 2026-02-17
Clinical Trial Update: SH-DS01 on Fecal Metagenomic Stability [Phase 2]
Summary
Phase 2 study SH-DS01 assessing fecal metagenomic stability in irritable bowel syndrome has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Beth Israel Deaconess Medical Center | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2026-02-17